2013
DOI: 10.1016/j.bmc.2012.11.053
|View full text |Cite
|
Sign up to set email alerts
|

Use of biosynthetic enzymes in heparin and heparan sulfate synthesis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
23
0

Year Published

2013
2013
2020
2020

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 38 publications
(23 citation statements)
references
References 48 publications
0
23
0
Order By: Relevance
“…HS chains are made up of variably sulfated and N-acetylated repeating disaccharide unites, i.e. glucuronic/iduronic acid and glucosamine (Chappell & Liu, 2013;Linhardt, 2003;Sakiyama-Elbert, 2014). Heparin, the most highly sulfacted heparan sulfate, has been widely used as the most effective clinical anticoagulant.…”
Section: Bioactive Polysaccharides From Other Sourcesmentioning
confidence: 99%
“…HS chains are made up of variably sulfated and N-acetylated repeating disaccharide unites, i.e. glucuronic/iduronic acid and glucosamine (Chappell & Liu, 2013;Linhardt, 2003;Sakiyama-Elbert, 2014). Heparin, the most highly sulfacted heparan sulfate, has been widely used as the most effective clinical anticoagulant.…”
Section: Bioactive Polysaccharides From Other Sourcesmentioning
confidence: 99%
“…To generate synthetic heparin with controllable structural and functional profiles, a different combined chemoenzymatic approach was also recently developed Chappell and Liu, 2013;DeAngelis et al, 2013). The enzymes of heparin/HS biosynthesis, expressed in E. coli or insect cells, may be used for postpolymerization transformations of a heparosan-like polymer made using bacterial enzymes.…”
Section: E Synthetic Heparinmentioning
confidence: 99%
“…11,12 Natural isolates are frequently inhomogeneous, making structural characterization difficult. Here, we capitalize on a synthetic strategy directed at the preparation of HS with specific sulfation patterns (Figure.…”
mentioning
confidence: 99%